Description

Volume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology.

Readership

Pharmacologists, medicinal chemists, and toxicologists.

Table of Contents

L.B. Kier and B. Testa, Complexity and Emergence in Drug Research. M.S. Tute, Drug Design: the Present and the Future. K. Burki and B. Ledermann, Transgenic Animals as Pharmacological Tools. C.L. Crespi, Xenobiotic-metabolizing Human Cells as Tools for Pharmacological and Toxicological Research. J. Urquhart, Correlates of Variable Patient Compliance in Drug Trials: Relevance in the New Health Care Environment. Subject Index. Cumulative Index of Authors. Cumulative Index of Titles.

Details

No. of pages:
279
Language:
English
Copyright:
© 1995
Published:
Imprint:
Academic Press
eBook ISBN:
9780080526690
Print ISBN:
9780120133260
Print ISBN:
9780123909060

About the serial-volume-editors

Bernard Testa

Affiliations and Expertise

University Hospital Centre, Lausanne, Switzerland

Urs Meyer

Affiliations and Expertise

Biocentre, University of Basel, Switzerland

Reviews

Volume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology.